Mitsuaki Ohtani
Directeur/Membre du Conseil chez The Cell Science Research Foundation
Provenance du réseau au premier degré de Mitsuaki Ohtani
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
The Cell Science Research Foundation
5
| Foundation/Endowment | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mitsuaki Ohtani via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| SHIONOGI & CO., LTD. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| Shionogi General Service Co., Ltd. | Comptroller/Controller/Auditor | ||
Sumitomo Mitsui Banking Corp.
 Sumitomo Mitsui Banking Corp. Major BanksFinance Sumitomo Mitsui Banking Corp. engages in the provision of financial services centered on banking. It operates through the following business segments: Wholesale, Retail, International, Market Sales, and Headquarters Management. The Wholesale segment covers business for customers of large and medium-sized companies in Japan. The Retail segment handles business for domestic individuals and SME customers. The International segment comprises of business for overseas Japanese and non-Japanese companies. The Market Sales segment corresponds to financial market business. The Headquarters Management segment includes all other businesses not covered by other segments. The company was founded in April 2001 and is headquartered in Tokyo, Japan. | Major Banks | Director/Board Member | |
| AGC INC. | Home Furnishings | Director/Board Member | |
Nippon Venture Capital Corp.
 Nippon Venture Capital Corp. Investment ManagersFinance Nippon Venture Capital Corp. (NVCC) is an independent venture capital firm headquartered in Tokyo, Japan. The firm was established in 1996. | Investment Managers | Director/Board Member | |
Shionogi Pharma Co., Ltd.
 Shionogi Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Shionogi Pharma Co. Ltd. engages in the manufacture, sale, analysis and testing of ethical drugs and investigational drugs. The company was founded on October 1, 2018 and is headquartered in Osaka, Japan. | Pharmaceuticals: Major | President | |
| FREUND CORPORATION | Industrial Machinery | Director/Board Member |
Statistiques
Internationale
| Japon | 8 |
Sectorielle
| Health Technology | 3 |
| Finance | 3 |
| Consumer Durables | 2 |
| Producer Manufacturing | 2 |
Opérationnelle
| Director/Board Member | 12 |
| Corporate Officer/Principal | 5 |
| Chairman | 3 |
| Comptroller/Controller/Auditor | 2 |
| President | 2 |
Relations les plus connectées
| Insiders | |
|---|---|
| Isao Teshirogi | 5 |
| Ryuichi Kume | 4 |
| Sachio Tokaji | 3 |
| Motozo Shiono | 2 |
| Hirosato Kondo | 2 |
- Bourse
- Insiders
- Mitsuaki Ohtani
- Connexions Sociétés
